Bionexus gene lab corp. completes strategic rm 1 million investment in ascension innovation sdn bhd

Kuala lumpur, malaysia, aug. 27, 2024 (globe newswire) -- bionexus gene lab corp. (nasdaq: bglc), an emerging leader in genomic diagnostics and health technology, today announced the successful closing of its rm 1 million (approx. usd228k) investment in ascension innovation sdn bhd (aisb), a pioneering malaysian healthcare technology firm. this strategic investment, executed through bglc's wholly-owned subsidiary, mrna scientific sdn bhd, solidifies bglc's commitment to advancing ai-driven healthcare solutions.
BGLC Ratings Summary
BGLC Quant Ranking